| Ms Sarika Gupta, MBBS | |
|
200 Hawkins Dr, Iowa City, IA 52242-1009 | |
| (319) 384-9609 | |
| (319) 384-9613 |
| Full Name | Ms Sarika Gupta |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 17 Years |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992110100 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhatti Gastroenterology Consultants Pa | 3678890209 | 10 |
News Archive
Global Health Partner's (STO:GHP) CEO Per Båtelson and Deputy CEO Johan Wachtmeister have utilized existing share purchase warrants and acquired 527,444 and 527,445 shares, respectively, in Global Health Partner. The warrants were issued by a number of Global Health Partner's shareholders, mainly by Metroland BVBA, and the strike price was 75 pence, corresponding to approximately SEK 8.75.
At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus, two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease risk in people with HIV with significant implications for improving medical care.
Infectious diseases pose a serious threat to the nation's public health. Today, experts addressed key developments to the current and future outlook of infectious diseases, highlighting adolescent immunizations, outbreaks and epidemics of infectious diseases, antimicrobial resistance and new developments in HIV medicine, at a press conference sponsored by the National Foundation for Infectious Diseases (NFID).
Techulon Inc., a life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new, traceable DNA delivery platform created to deliver genetic medicine to cells while carrying a beacon so scientists can follow its progress.
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.
› Verified 6 days ago
| Entity Name | Bhatti Gastroenterology Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467886341 PECOS PAC ID: 3678890209 Enrollment ID: O20150319001692 |
News Archive
Global Health Partner's (STO:GHP) CEO Per Båtelson and Deputy CEO Johan Wachtmeister have utilized existing share purchase warrants and acquired 527,444 and 527,445 shares, respectively, in Global Health Partner. The warrants were issued by a number of Global Health Partner's shareholders, mainly by Metroland BVBA, and the strike price was 75 pence, corresponding to approximately SEK 8.75.
At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus, two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease risk in people with HIV with significant implications for improving medical care.
Infectious diseases pose a serious threat to the nation's public health. Today, experts addressed key developments to the current and future outlook of infectious diseases, highlighting adolescent immunizations, outbreaks and epidemics of infectious diseases, antimicrobial resistance and new developments in HIV medicine, at a press conference sponsored by the National Foundation for Infectious Diseases (NFID).
Techulon Inc., a life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new, traceable DNA delivery platform created to deliver genetic medicine to cells while carrying a beacon so scientists can follow its progress.
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sarika Gupta, MBBS 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 384-9609 | Ms Sarika Gupta, MBBS 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 384-9609 |
News Archive
Global Health Partner's (STO:GHP) CEO Per Båtelson and Deputy CEO Johan Wachtmeister have utilized existing share purchase warrants and acquired 527,444 and 527,445 shares, respectively, in Global Health Partner. The warrants were issued by a number of Global Health Partner's shareholders, mainly by Metroland BVBA, and the strike price was 75 pence, corresponding to approximately SEK 8.75.
At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus, two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease risk in people with HIV with significant implications for improving medical care.
Infectious diseases pose a serious threat to the nation's public health. Today, experts addressed key developments to the current and future outlook of infectious diseases, highlighting adolescent immunizations, outbreaks and epidemics of infectious diseases, antimicrobial resistance and new developments in HIV medicine, at a press conference sponsored by the National Foundation for Infectious Diseases (NFID).
Techulon Inc., a life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new, traceable DNA delivery platform created to deliver genetic medicine to cells while carrying a beacon so scientists can follow its progress.
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.
› Verified 6 days ago
Dr. John Phillip Lee, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Pathology, Iowa City, IA 52242 Phone: 319-384-9605 Fax: 319-467-5193 | |
Dr. Carol Joy Holman, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-3981 Fax: 319-384-8051 | |
James A Goeken, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1966 Fax: 319-384-8053 | |
Sergei I Syrbu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-7372 Fax: 319-384-8053 | |
Jo A Benda, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4436 Fax: 319-384-8052 | |
Amani Abdalla Bashir, MBBS Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Drive, University Of Iowa Hospitals And Clinics, Iowa City, IA 52242 Phone: 319-467-5706 Fax: 319-356-8470 | |
Mr. Paul J Belding, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 321 E Market St Ste 102, Iowa City, IA 52245 Phone: 319-337-7284 Fax: 319-337-7284 |